Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Isabelle Desombere
Observed names:
Desombere, Isabelle,
I DESOMBERE,
I Desombere,
I. Desombere
Institution:
Sciensano (Belgium)
Observed institutions:
Université Libre de Bruxelles,
Ghent University Hospital,
Ghent University,
AZ Sint-Jan,
Sciensano (Belgium),
Instituut voor Tropische Geneeskunde
show all 6
ORCID:
0000-0003-3521-7712
Observed ORCID:
0000-0003-3521-7712
OpenAlex ID:
A5052118134
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies
2007
·
Jennifer M. Timpe
, Zania Stamataki
, et al.
·
Hepatology
·
391
PDF
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo
2008
·
Philip Meuleman
, Joseph Hesselgesser
, et al.
·
Hepatology
·
229
Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
1998
·
S. Thoelen
, P. Van Damme
, et al.
·
Vaccine
·
156
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011
·
Philip Meuleman
, Maria Teresa Catanese
, et al.
·
Hepatology
·
143
PDF
Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain
2008
·
Thomas Vanwolleghem
, Jens Bukh
, et al.
·
Hepatology
·
140
Response to hepatitis B vaccine: multiple HLA genes are involved
1998
·
I. Desombere
, A. Willems
, et al.
·
Tissue Antigens
·
139
In Vivo Evaluation of the Cross-Genotype Neutralizing Activity of Polyclonal Antibodies Against Hepatitis C Virus Δσ
2011
·
Philip Meuleman
, Jens Bukh
, et al.
·
Hepatology
·
132
PDF
Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay
2020
·
Joachim Mariën
, Ann Ceulemans
, et al.
·
Journal of Virological Methods
·
110
PDF
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
2021
·
M. Peeters
, L. Verbruggen
, et al.
·
ESMO Open
·
95
PDF
The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population
2002
·
P Jacques
, G Moens
, et al.
·
Vaccine
·
93
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers
2004
·
Geert Leroux-Roels
, Erik Depla
, et al.
·
Vaccine
·
82
Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice
2010
·
Thomas Vanwolleghem
, Louis Libbrecht
, et al.
·
Journal of Hepatology
·
75
Long‐term persistence of antibodies induced by vaccination and safety follow‐up, with the first combined vaccine against hepatitis A and B in children and adults
2001
·
P. Van Damme
, G. Leroux‐Roels
, et al.
·
Journal of Medical Virology
·
72
Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa
1996
·
G Leroux-Roels
, C A Esquivel
, et al.
·
Hepatology
·
72
PDF
Persistence of IgG response to SARS-CoV-2
2020
·
Els Duysburgh
, Laure Mortgat
, et al.
·
The Lancet Infectious Diseases
·
70
PDF
Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes.
1995
·
I Desombere
, P Hauser
, et al.
·
The Journal of Immunology
·
70
Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries
2021
·
Guy Berbers
, Pieter van Gageldonk
, et al.
·
Nature Communications
·
68
A hepatitis B vaccine formulated with a novel adjuvant system
2000
·
F. Ambrosch
, G. Wiedermann
, et al.
·
Vaccine
·
60
Hepatitis B Virus Core Antigen Binds and Activates Naive Human B Cells In Vivo: Studies with a Human PBL-NOD/SCID Mouse Model
2001
·
Tinghua Cao
, Una Lazdina
, et al.
·
Journal of Virology
·
59
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
2021
·
Lorenzo Canti
, Stéphanie Humblet-Baron
, et al.
·
Journal of Hematology & Oncology
·
52
PDF
Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines
2000
·
I Desombere
, Y Gijbels
, et al.
·
Clinical & Experimental Immunology
·
48
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
2022
·
Kevin K. Ariën
, Leo Heyndrickx
, et al.
·
npj Vaccines
·
45
PDF
Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum
2012
·
Frederic Clement
, Vincent Dewar
, et al.
·
Malaria Journal
·
44
PDF
Immunogenicity and Tolerability of Intradermal Administration of an HCV E1-Based Vaccine Candidate in Healthy Volunteers and Patients with Resolved or Ongoing Chronic HCV Infection
2005
·
Geert Leroux-Roels
, Arsène-Hélène Batens
, et al.
·
Human Vaccines
·
44
PDF
Polyfunctional CD4+ T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine
2013
·
Eva Van Braeckel
, Isabelle Desombere
, et al.
·
Vaccine
·
43
Show more works
View as search
Works count:
136
Citation count:
3,434
H-index:
35
I10-index:
56
Year
Topic
Type
